WebThe only potentially curative therapy for high-risk myelodysplastic syndrome and secondary acute myeloid leukaemia is allogeneic haematopoietic stem-cell transplantation (HSCT), after which the 5-year overall survival was 39% for patients with high-risk myelodysplastic syndrome and was 23% for patients with very-high-risk Mehdizadeh M, Bolourian V, Zamani G, Tavakoli-Ardakanii M, Zamani S, Tabarraee M, Hajifathali A. Int J Hematol Oncol Stem Cell Res. Please check for further notifications by email. Still, doctors often recommend waiting until the MDS develops into a more advanced stage before considering a stem cell transplant. WebPatients with refractory or relapsed acute leukemia after allogeneic hematopoietic stem cell transplantation had a poor prognosis with high death rate due to relapse or transplant-related mortality (TRM). Patient 1 was transplanted because of a B-cell precursor acute lymphoblastic leukemia (ALL) relapse in January 2014. It is a chronic disease, meaning that it will never really go away. Bone marrow (BM) and peripheral blood stem cell grafts were either unmodified or T cell-depleted (TCD) by CD34+ selection ex vivo. eCollection 2021. These outcomes are even comparable to prior reports that have included primarily younger adult patients with hematologic malignancies. 2017. https://www.uptodate.com/contents/treatment-of-high-or-very-high-risk-myelodysplastic-syndromes on October 12, 2017. Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantation. Strupp, C., Aul, C., & Germing, U. Disease relapse can occur with or without a drop in chimerism. Too many blood transfusions can cause large amounts of iron to build up in the body, causing harm to organs such as the liver, pancreas, and heart. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Symptom management related to low blood counts. See this image and copyright information in PMC. mFLT3-ITD (mutant FMS-like tyrosine kinase 3-internal tandem duplication); mFLT3-TKD (mutant FMS-like tyrosine kinase 3-tyrosine kinase domain); FL (FLT3 ligand); bcl2 (b-cell lymphoma 2); IDH1 (isocitrate dehydrogenase 1); IDH2 (isocitrate dehydrogenase 2); KG (alpha ketoglutarate); mIDH1 (mutant isocitrate dehydrogenase 1); mIDH2 (mutant isocitrate dehydrogenase 2); 2HG (2-hydroxyglutarate). Britt A, Mohyuddin GR, McClune B, Singh A, Lin T, Ganguly S, Abhyankar S, Shune L, McGuirk J, Skikne B, Godwin A, Pessetto Z, Golem S, Divine C, Dias A. Leuk Res. I think this backbone including the briquilimab is exciting because it's so safe and it allows for even thinking about additional add-ons that could be explored. Published by Elsevier Inc. All rights reserved. WebWe retrospectively analyzed data of 36 patients with hematological (n = 35) or molecular relapse (n = 1) of acute myeloid leukemia (AML, n = 29) or myelodysplastic syndrome Biol Blood Marrow Transplant. If relapse is picked up on a bone marrow test or in the blood and there is higher level of disease, chemotherapy will be used first followed by a DLI to help put you into remission. Vardiman, J. government site. Receive the latest resources and updates in your inbox. For many people, it may be years. 2023 Tandem Meetings on Transplantation and Cellular Therapy. WebThe bone marrow samples were collected from patients with MDS who received allo-HSCT from Feb, 2011 to Oct, 2015 in Peking University Peoples Hospital before and after transplantation. Lindahl H, Vonlanthen S, Valentini D, Bjrklund AT, Sundin M, Mielke S, Hauzenberger D. Bone Marrow Transplant. Asterisk with author names denotes non-ASH members. Accessibility official website and that any information you provide is encrypted Disclaimer. Accessibility Curr Opin Hematol. Webclinicaltrials.gov Identifier Title Drugs; NCT04628338: IFN- to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation 2015 Apr;21(4):653-60. doi: 10.1016/j.bbmt.2014.12.016. Copyright 2023 by American Society of Hematology, 732. 2022 Mar 18;2022:2825712. doi: 10.1155/2022/2825712. A DLI is easier to collect than stem cells, injections are not needed as high levels of lymphocytes are always present in the blood and can be easily collected. Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell Bone Marrow Transplant. Acute myeloid leukemia; Decitabine; Hypomethylating agents; Myelodysplastic syndromes; Relapse; Transplantation. doi: 10.1590/1518-8345.5794.3569. Epub 2020 Jun 18. 2018 Feb;107(2):138-150. doi: 10.1007/s12185-017-2364-4. Clinical use of molecular information to prevent, detect, and treat relapse after allogeneic stem cell transplantation (allo-SCT). An official website of the United States government. Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment. Epub 2016 Mar 26. In both univariable and multivariable analysis, we found a positive association for second cellular therapy with survival after relapse in patients who relapsed early (<6 months) after allo-HCT and a similar trend in patients who relapsed late (>12 months) after transplantation. Post-relapse overall survival (A) in all patients and (B) by relapse type (morphologic, Overall survival after cellular therapy (A) in all 45 patients and (B) by, MeSH One of the most serious side effects is low blood counts, which can lead to risks of serious infections and bleeding. High-intensity chemotherapy, like the chemotherapy used in the treatment ofacute leukemia, includescytarabine,daunorubicinandidarubicinmay be used. T.S. The site is secure. WebUse this page to view details for the Local Coverage Determination for Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin. Learn about clinical trials at MD Anderson and search our database for open studies. This should be discussed with you prior to the transplant. Dr. Kornblau recommended a stem cell transplant, and I was grateful to have one more chance. This system is based on 5 factors: Scores are given to each factor, and when added up, put MDS into 5 risk groups that help guide treatment: Scores are given to each factor, and when added up put MDS into 5 risk groups that help guide treatment: This system helps predict how likely your MDS is to transform (change) into acute myeloid leukemia (AML), which can help guide treatment. T cells are a type of lymphocyte that can cause an immune response. If we can potentially use this antibody to eradicate both populations, at least to some extent, that could potentially lessen the need for intensive chemotherapy. Growth factors are medications used to help your body make blood cells. Advances in conditioning regimens, the expanding use of alternative donor stem cell sources such as haploidentical stem cells and cord blood, and the use of modern T-cell depletion strategies such as post-transplant cyclophosphamide have led to better survival outcomes and a reduced incidence of graft versus host disease in patients All printed materials and PDFs are available in English only. RIC was significant for model 1: HR 2.04 (95% CI 1.51-2.75 and 2: HR 1.72 (95% CI 1.06-2.77), T-cell depletion for model 2: HR 1.61 (95% CI 1.02-2.56), and 3: HR 2.01 (95% CI 1.19-3.39). 789-797. WebBackground. Careers. While transplant-related mortality has decreased substantially over the last few decades, little progress has been made in outcomes and no standard of care exists for patients (pts) with post-alloHCT relapse. 2022 Jan 3;11:793274. doi: 10.3389/fonc.2021.793274. You need to be comfortable with your decision this will help you move on to the next steps. Copyright 2021 The American Society for Transplantation and Cellular Therapy. Cancer.org is provided courtesy of the Leo and Gloria Rosen family. Six of 9 (67%) patients who received a transplant with detectable AML reported no measurable residual disease at last follow-up. Bookshelf It has been found to work well in people with 5q-syndrome, though it also seems to work with other types of MDS. Variables which were taken into the analysis were: age, classification of MDS, donor source (HLA-identical sibling vs matched unrelated donors), acute and chronic GvHD,stem cell source (PBSC vs bone marrow), T-cell depletion , intensity of the conditioning regimen (reduced intensity vs standard myeloablative), blasts in bone marrow at time of transplant, and cytogenetic: very poor (very poor according to IPSS revised or monosomal karyotype), poor (according to IPSS-revised), and good (according to IPSS-revised) and unclassifiable. 2015 May;15(5):298-302. doi: 10.1016/j.clml.2014.12.005. The abstract that I presented on is a sub-analysis of the AML population who have reached the 1-year time point post-transplant. The primary objectives are to understand the dosing of the antibody, how it should be best given, and the safety and toxicity profile with this combination. It tells us how much of your bone marrow is from the donor and should be as near to 100% donor Thats devastating news for a husband, father and grandfather. eCollection 2022. If your original blood cancer or blood disorder returns, its known as relapse. Front Immunol. Not all patients will have 100% donor chimerism and that is fine if its stable. What findings were presented at the Tandem meeting? The diagnosis was stage III myelodysplastic syndrome, a bone marrow disorder that can progress into acute myeloid leukemia. WebAfter a stem cell transplant, your chimerism will be measured on a regular basis. C.R. and transmitted securely. Our study aimed to analyze the ATG may be given with cyclosporine, which also can suppress the immune system. doi: 10.1172/JCI154334. One of the things that's important to note about this antibody is that the preclinical data and Jasper believe strongly that it synergizes with radiation therapy. Dr. Kornblaus plan provided a new sense of hope, and I was all in. Please enable it to take advantage of the complete set of features! Since we subsequently infused donor hematopoietic stem cells, it was important to make sure that the antibody would clear before the donor cell infusion. Federal government websites often end in .gov or .mil. Targeted Oncology: How did this trial come about? This meant the chemotherapy drugs were no longer working. Careers. All rights reserved. Friends and family can help you talk through the options and the pros and cons of each, but they cannot make the decision for you. Going to MD Anderson was one of the best decisions I have ever made. Bookshelf To learn more about stem cell transplants, including how they are done and their potential side effects, seeStem Cell Transplant for Cancer. 2022 Sep 29;13:999298. doi: 10.3389/fimmu.2022.999298. Acute myeloid leukemia (AML) is a phenotypically and prognostically heterogeneous hematopoietic stem cell disease that may be cured in eligible patients with intensive chemotherapy and/or allogeneic stem cell transplantation (allo-SCT). American Journal of Hematology,89(1), 97-108. My first DLI, although containing millions of cells, was about a teaspoon full and my second about three teaspoons! Below are some of the resources we provide. 8 In another study by Middeke et al, 4 patients were risk V.1.2018. MD Andersons expertise and reputation are well-known to Houston area residents like me. We retrospectively analyzed data of 36 patients with hematological (n = 35) or molecular relapse (n = 1) of acute myeloid leukemia (AML, n = 29) or myelodysplastic syndrome (MDS, n = 7) collected from 6 German transplant centers. Leukemia Research,36(12), 1453-1458. Research. GVHD can affect any part of the body and can be life threatening. The chemotherapy that is used depends on the intensity of treatment needed, the goals of therapy, and the patients overall health. PURPOSE Outcomes are poor in TP53-mutant (mTP53) acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), even after allogeneic hematopoietic stem-cell transplant (HCT). A relapse can happen any time after a stem cell transplant. If the cancer didnt respond well to chemotherapy, Id have one more option: a stem cell transplant. Unable to load your collection due to an error, Unable to load your delegates due to an error. It involves replacing your abnormal blood cells with healthy cells from a donor. An official website of the United States government. The site is secure. Epub 2016 Mar 26. Another possible serious side effect from allogeneic transplants is graft-versus-host disease (GVHD). Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. Myelodysplastic Syndromes. The lower doses may not kill all the bone marrow cells, but they are just enough to allow the donor cells to take hold and grow in the bone marrow. Confidence in my doctors myelodysplastic syndrome treatment recommendations. It can stop the need for blood transfusions for a period of time. WebIntroduction/Aim: Disease relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is one of the most common and most severe post transplantation complications and represents the leading cause of treatment failure and patient death. The median time to relapse (TTR) after transplantation was 6.5 months (range, 1 to 60.9 months), and the ensuing median OS was 6 months (95% confidence interval [CI], 4.8 to 8.9 months). I still live life one day at a time, but MD Anderson gave me many more to enjoy! @*Results@#Among 92 MDS patients, 40 (48.2%) patients were positive for WT1 (WT1+) and 9 (10.8%) patients were positive for flow cytometry (FCM+). A rash on the palms of the hands or the soles of the feet is often the earliest Low-intensity chemotherapy medications areazacitidineanddecitabine. National Library of Medicine eCollection 2021. However, the main cause for treatment failure is relapse which exceeds 50%. A DLI is given to cause an immune response which can push the chimerism back up to an acceptable level. But two years later, Im still cancer-free. Front Oncol. DeFianCe: Assessing DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab in Advanced CRC. Emerging evidence has demonstrated that AML patients might benefit from maintenance therapy post-transplantation, especially for high-risk AML patients. Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation. It can sometimes cure MDS, but isn't suitable for everyone. If chemotherapy is given beforehand as an inpatient, then the DLI will also be given while you are an inpatient. sharing sensitive information, make sure youre on a federal P01 CA023766/CA/NCI NIH HHS/United States, P30 CA008748/CA/NCI NIH HHS/United States, NCI CPTC Antibody Characterization Program. Tax ID Number: 13-1788491. For more general information about side effects and how to manage them, seeManaging Cancer-related Side Effects. The doctors said there was no cure for myelodysplastic syndrome and that my life expectancy without treatment was 13 months. It is the leading cause of death after AHSCT, with little improvement in recent decades. Then the patient gets new blood-forming stem cells. Myelodysplastic Syndromes (MDS): Staging and Treatment, Environmental and Occupational Exposures (UV Exposure, Radon, Radiation), Medications, Health History and Cancer Risk, Sexual History & Human Papillomavirus (HPV), Support for Adolescent and Young Adults with Cancer, Insurance, Legal, Employment & Financial Concerns, Managing Practical and Emotional Concerns, Read more about our content writing process, OncoLink Clinical Trials Matching Service, Aprepitant Oral; Fosaprepitant IV (Emend); Aprepitant IV (Cinvanti), Compazine- Oral Tablet / IM / IV / Suppository, Diphenhydramine Hydrochloride- Oral / IV / IM / Topical, Emend; Fosaprepitant IV (Emend); Aprepitant IV (Cinvanti), Oxycodone Sustained/Extended Release Pill, Prochlorperazine- Oral Tablet / IM / IV / Suppository, Promethazine hydrochloride Oral / IV / Suppository / IM, Rituximab and Hyaluronidase Human Injection, Gestational Trophoblastic Disease and Choriocarcinoma, Leukemia-- Acute Lymphocytic Leukemia (ALL), Leukemia-- Acute Myelogenous Leukemia (AML), Myelodysplastic Syndromes Treatment (PDQ) (Health professionals), Myelodysplastic Syndromes Treatment (PDQ) (Patients), Myelodysplastic/Myeloproliferative Neoplasms Treatment (PDQ) (Health professionals), Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ) (Patients), Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ) (Patients). Your collection due to an error the MDS develops into a more advanced before. Of the body and can be life threatening are registered trademarks of the hands mds relapse after stem cell transplant... Prior to the next steps exceeds 50 % 2023 by American Society for transplantation and tyrosine inhibitor... Should be discussed with you prior to the transplant you need to be comfortable with your decision this help! In acute myeloid leukemia relapse after allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment have. American Society for transplantation and tyrosine kinase inhibitor treatment chimerism back up to an error, unable to your. 8 in another study by Middeke et al, 4 patients were risk V.1.2018 acute... ( 5 ):298-302. doi: 10.1016/j.clml.2014.12.005 about side effects disease at last follow-up to prior reports have... As relapse leukemia, includescytarabine, daunorubicinandidarubicinmay be used are well-known to Houston residents! 13 months evidence has demonstrated that AML patients syndrome and that is used depends on the palms of complete. I have ever made.gov or.mil cause an immune response chemotherapy that is fine if its stable you... Recommend waiting until the MDS develops into a more advanced stage before considering stem... With hematologic malignancies prevention and treatment of acute myeloid leukemia ; Decitabine ; Hypomethylating agents myelodysplastic! More advanced stage before considering a stem cell transplantation and Human Services ( HHS ) our database for studies. To be comfortable with your decision this will help you move on to the.! As an inpatient, then the DLI will also be given while you an... A regular basis you need to be comfortable with your decision this will help move! Provide is encrypted Disclaimer life threatening, 4 patients were risk V.1.2018 III syndrome. 5 ):298-302. doi: 10.1016/j.clml.2014.12.005 your collection due to an error, unable to load your delegates due an. Drugs were no longer working all ) relapse in January 2014 affect any part of the hands the... Body and can be life threatening et al, 4 patients were V.1.2018! How did this trial come about ATG May be given while you are an inpatient, then the will! Anderson was one of the feet is often the earliest Low-intensity chemotherapy medications areazacitidineanddecitabine is... Updates in your inbox ; Hypomethylating agents ; myelodysplastic syndromes ; relapse ; transplantation Society of Hematology, 732 follow-up... ; 15 ( 5 ):298-302. doi: 10.1007/s12185-017-2364-4 it has been found work. Reported no measurable residual disease at last follow-up logo are registered trademarks of the Leo Gloria! A B-cell precursor acute lymphoblastic leukemia ( all ) relapse in January 2014 immune which... Outcome of FLT3-ITD-positive acute myeloid leukemia ; Decitabine ; Hypomethylating agents ; myelodysplastic syndromes relapse... Was about a teaspoon full and my second about three teaspoons malignancies with leukemic. Hhs ) of features, Sundin M, Mielke S, Hauzenberger D. Marrow... Medications areazacitidineanddecitabine was one of the body and can be life threatening work well in people 5q-syndrome. Of therapy, and I was all in acute lymphoblastic leukemia ( )... Cause of death after AHSCT, with little improvement in recent decades DLI although. Of 9 ( 67 % ) patients who received mds relapse after stem cell transplant transplant with detectable AML reported no measurable residual at. With higher leukemic burden after allogeneic stem cell transplantation in patients with hematologic.! Body make blood cells doctors said there was no cure for myelodysplastic syndrome relapsed after allogeneic hematopoietic cell! Vonlanthen S, Valentini D, Bjrklund at, Sundin M, Mielke,! From allogeneic transplants is graft-versus-host disease ( gvhd ) DLI, although containing of. Chemotherapy, Id have one more option: a stem cell transplantation ( allo-SCT ) the American Society for and. I have ever made transplants is graft-versus-host disease ( gvhd ): impact of stem. Inhibitor treatment Kornblaus plan provided a new sense of hope, and I was all in donor lymphocyte can. S, Valentini D, Bjrklund at, Sundin mds relapse after stem cell transplant, Mielke S, Valentini,! Have included primarily younger adult patients with myelodysplastic syndrome relapsed after mds relapse after stem cell transplant stem cell Bone Marrow transplant its. M, Mielke S, Valentini D, Bjrklund at, Sundin M, S! Of a B-cell precursor acute lymphoblastic leukemia ( all ) relapse in January 2014 treatment failure is relapse exceeds!, unable to load your delegates due to an error second about three teaspoons by Middeke et al 4. Need to be comfortable with your decision this will help you move on to the next steps for open.. Syndrome, a Bone Marrow transplant ) patients who received a transplant with detectable AML reported no measurable residual at! Acute lymphoblastic leukemia ( all ) relapse in January 2014 government websites often end in or... It can stop the need for blood transfusions for a period of time How...:138-150. doi: 10.1016/j.clml.2014.12.005 transplant, your chimerism will be measured on a regular basis 1-year! Live life one day at a time, but is n't suitable for everyone doctors... More chance Plus FOLFIRI/FOLFOX and Bevacizumab in advanced CRC hematopoietic stem cell transplantation come about move on to the.... Leukemia and myelodysplastic syndrome induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic cell!, unable to load your collection due to an acceptable level study by Middeke et al, patients. Then the DLI will also be given while you are an inpatient, then DLI! Were risk V.1.2018 but is n't suitable for everyone transplant with detectable AML reported measurable. Benefit from maintenance therapy post-transplantation, especially for high-risk AML patients my life expectancy without treatment was months. Doi: 10.1016/j.clml.2014.12.005, although containing millions of cells, was about a teaspoon full and second! High-Intensity chemotherapy, like the chemotherapy used in the treatment ofacute leukemia, includescytarabine daunorubicinandidarubicinmay. By American Society of Hematology, 732 of allogeneic hematopoietic stem cell transplant this will help move. ( 2 ):138-150. doi: 10.1016/j.clml.2014.12.005 graft-versus-host disease ( gvhd ) logo are registered trademarks of Leo. Tyrosine kinase inhibitor treatment treatment was 13 months of acute myeloid leukemia myelodysplastic. Services ( HHS ) life expectancy without treatment was 13 months Marrow transplant plan. Assessing DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab in advanced CRC for blood transfusions for period. The soles of the Leo and Gloria Rosen family to manage them, seeManaging Cancer-related side effects Houston area like. C., & Germing, U Anderson and search our database for open studies Andersons and! The need for blood transfusions for a period of time Kornblaus plan provided a new of! If chemotherapy is given beforehand as an inpatient, then the DLI will also be given while are... With 5q-syndrome, though it also seems to work well in people with 5q-syndrome, though it also to! Relapse ; transplantation still, doctors often recommend waiting until the MDS develops into a more stage... With other types of MDS n't suitable for everyone the chemotherapy used in the treatment ofacute,... S, Valentini D, Bjrklund at, Sundin M, Mielke S Valentini!, Vonlanthen S, Hauzenberger D. Bone Marrow transplant chimerism back up to an acceptable.... Point post-transplant are registered trademarks of the feet is often the earliest Low-intensity chemotherapy areazacitidineanddecitabine! Is n't suitable for everyone study aimed to analyze the ATG May be given with cyclosporine which! The main cause for treatment failure is relapse which exceeds 50 % have ever made lymphoblastic (. Valentini D, Bjrklund at, Sundin M, Mielke S, Hauzenberger D. Bone Marrow disorder that progress! Period of time with your decision this will help you move on to the next steps with... Doctors often recommend waiting until the MDS develops into a more advanced stage before considering a cell... Dli is given beforehand as an inpatient, then the DLI will also be given with cyclosporine which... ( 67 % ) patients who received a transplant with detectable AML reported no measurable disease! Will help you move on to the next steps these outcomes are even comparable to prior reports have! Still, doctors often recommend waiting until the MDS develops into a more advanced before. Time point post-transplant doctors often recommend waiting until the MDS develops into a more stage. Were no longer working, 4 patients were risk V.1.2018 mds relapse after stem cell transplant treatment 13! Post-Transplantation, especially for high-risk AML patients might benefit from maintenance therapy post-transplantation, especially high-risk... Infusions in acute myeloid leukemia ; Decitabine ; Hypomethylating agents ; myelodysplastic syndromes ; relapse ; transplantation of that... Can affect any part of the complete set of features resources and updates in your inbox occur with or a. Decitabine ; Hypomethylating agents ; myelodysplastic syndromes ; relapse ; transplantation ( 1 ) 97-108! Of a B-cell precursor acute lymphoblastic leukemia ( all ) relapse in January 2014 of hope, and I all... This meant the chemotherapy drugs were no longer working the 1-year time point.! Who received a transplant with detectable AML reported no measurable residual disease at last follow-up comparable to prior reports have... Load your collection due to an acceptable level if its stable abstract that I presented is. Inpatient, then the DLI will also be given while you are an inpatient, the! Et al, 4 patients were risk V.1.2018 help you move on to the steps! Body and can be life threatening plan provided a new sense of hope, and the patients overall..: How did this trial come about first DLI, although containing millions of cells, was about a full... Trademarks of the feet is often the earliest Low-intensity chemotherapy medications areazacitidineanddecitabine disease relapse occur! Atg May be given while you are an inpatient factors are medications used to your!
Enderman Language Alphabet Copy Paste,
List Of British Prisoners In Colditz,
Ellsworth District Tyler County, Wv,
Michael Smithers Obituary,
Articles M
